Bicara Therapeutics Inc. · NASDAQ:BCAX
Raben David sold 5,500 Bicara Therapeutics Inc. shares (Form 4)
Traded Apr 27, 2026 · Filed Apr 28, 2026
On Apr 27, 2026, Raben David (Chief Medical Officer) sold 5,500 Bicara Therapeutics Inc. shares at US$22.88 for US$126K under a trading plan, leaving 55,286 shares. Filed Apr 28, 2026 (Form 4).
- Sold
- 5,500 shares
- Price
- US$22.88
- Value
- US$126K
- Holding after
- 55,286 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | Option exercise | 5,500 | US$3.79 | 60,786 | Direct |
| Apr 27, 2026 | Common Stock | Sale | 5,500 | US$22.88 | 55,286 | Direct |
Source
Related
- Bicara Therapeutics Inc.
- Raben David
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026